02nd week of 2019 patent applcation highlights part 8 |
Patent application number | Title | Published |
20190008788 | PROCESS FOR ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS | 2019-01-10 |
20190008789 | GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL | 2019-01-10 |
20190008790 | A METHOD FOR THE PREPARATION OF A DELIVERY DRUG DELIVERY SYSTEM AND A COMPOSITION THEREFOR | 2019-01-10 |
20190008791 | LAMINATE CONTAINING CELL SHEET, AGENT FOR TREATING CARDIAC DISEASES, AND FILM FOR BEING LAMINATED ON CELL SHEET | 2019-01-10 |
20190008792 | BIOERODIBLE DRUG DELIVERY IMPLANTS | 2019-01-10 |
20190008793 | INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN | 2019-01-10 |
20190008794 | INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN | 2019-01-10 |
20190008795 | COMPOSITIONS FOR TOPICAL APPLICATION OF COMPOUNDS | 2019-01-10 |
20190008796 | FORMULA AND PRODUCT TO COMBAT CANNABIS INDUCED PARANOIA AND/OR ANXIETY | 2019-01-10 |
20190008797 | ESTROGEN RECEPTOR ALPHA COLIGANDS, AND METHODS OF USE THEREOF | 2019-01-10 |
20190008798 | Coenzyme Q10 in the preventive treatment of type 2 diabetes | 2019-01-10 |
20190008799 | COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT | 2019-01-10 |
20190008800 | COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFFECTS | 2019-01-10 |
20190008801 | COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFFECTS | 2019-01-10 |
20190008802 | USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS | 2019-01-10 |
20190008804 | Trans-Clomiphene and Progesterone Receptor Antagonist Combination Therapy for Treating Hormone-Dependent Conditions | 2019-01-10 |
20190008805 | BUPROPION AND DEXTROMETHORPHAN FOR TREATING NICOTINE ADDICTION | 2019-01-10 |
20190008806 | PHARMACEUTICAL COMPOSITION FOR NEUROPATHIC PAIN | 2019-01-10 |
20190008807 | TOPICAL AND TRANSDERMAL DELIVERY OF HIF-1 MODULATORS TO PREVENT AND TREAT CHRONIC WOUNDS | 2019-01-10 |
20190008808 | Use of Ureidomustine (BO-1055) in Cancer Treatment | 2019-01-10 |
20190008809 | REGULATORS OF THE ENDOPLASMIC RETICULUM PROTEOSTASIS NETWORK | 2019-01-10 |
20190008810 | METHOD FOR PREVENTION, TREATMENT AND ALLEVIATION OF INFECTIOUS DISEASES AND DISORDERS | 2019-01-10 |
20190008811 | SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION | 2019-01-10 |
20190008812 | METHODS FOR TREATING MICROGLIAL DYSFUNCTION | 2019-01-10 |
20190008813 | LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF | 2019-01-10 |
20190008814 | COMPOSITION FOR PREVENTING OR IMPROVING PERIPHERAL NEUROPATHY | 2019-01-10 |
20190008815 | SPRAYABLE AQUEOUS COMPOSITION COMPRISING GLYCERYL TRINITRATE | 2019-01-10 |
20190008816 | METHOD FOR EXTENDING LIFESPAN DELAYING THE ONSET OF AGE-RELATED DISEASE | 2019-01-10 |
20190008817 | Methods of Treating Multiple Sclerosis | 2019-01-10 |
20190008818 | Fumarate Ester Pharmaceutical Compositions | 2019-01-10 |
20190008819 | Methods and Compositions Using Cetyl Myristoleate (CMO) In Medical Treatments | 2019-01-10 |
20190008820 | COMPOSITION CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ASTHMA | 2019-01-10 |
20190008821 | METHODS FOR TREATING OBESITY | 2019-01-10 |
20190008822 | MULTI-ARM POLYMERIC PRODRUG CONJUGATES OF TAXANE-BASED COMPOUNDS | 2019-01-10 |
20190008823 | SUPPOSITORIES COMPRISING CANNABINOIDS | 2019-01-10 |
20190008824 | COCOA POLYPHENOLS AND SOLUBLE DIETARY FIBER FOR USE IN THE TREATMENT OR PREVENTION DISORDERS ASSOCIATED WITH AN ABOVE-NORMAL NUMBER OF GRANULOCYTES IN A TISSUE | 2019-01-10 |
20190008825 | COMPOSITIONS AND METHODS FOR SKIN CARE | 2019-01-10 |
20190008826 | USE OF BUTYLIDENEPHTHALIDE | 2019-01-10 |
20190008827 | ANTIOXIDATIVE STRESS COMPOSITIONS, METHODS OF PREPARING AND USES THEREOF | 2019-01-10 |
20190008828 | METHODS FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS (HIV) RELEASE FROM INFECTED CELLS | 2019-01-10 |
20190008829 | ANTI-NEOPLASTIC COMPOUNDS AND METHODS TARGETING QSOX1 | 2019-01-10 |
20190008830 | MICELLAR NANOCOMPLEX | 2019-01-10 |
20190008831 | ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS | 2019-01-10 |
20190008832 | COMPOSITIONS FOR THE TREATMENT OF PRESBYOPIA | 2019-01-10 |
20190008833 | NUCLEAR TRANSPORT MODULATORS AND USES THEREOF | 2019-01-10 |
20190008834 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DELIRIUM | 2019-01-10 |
20190008835 | COMPOSITIONS AND COMBINATIONS OF AUTOTAXIN INHIBITORS | 2019-01-10 |
20190008836 | HETEROCYCLIC COMPOUND | 2019-01-10 |
20190008837 | OPHTHALMIC COMPOSITIONS AND ASSOCIATED METHODS | 2019-01-10 |
20190008838 | Storage Stable Composition Comprising Rifaximin Alpha | 2019-01-10 |
20190008839 | HYPERPHENYLALANINEMIA AND TREATMENTS THEREOF | 2019-01-10 |
20190008840 | Bis-amines, Compositions, and Uses Related to CXCR4 Inhibition | 2019-01-10 |
20190008841 | COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS BY CONTROLLING BLOOD GLUCOSE LEVEL | 2019-01-10 |
20190008842 | DEUTERIUM-ENRICHED PIOGLITAZONE | 2019-01-10 |
20190008843 | PHARMACEUTICAL COMPOSITIONS FOR ON DEMAND ANTICOAGULANT THERAPY | 2019-01-10 |
20190008844 | Use of Flecainide as an Anti-Connexin Agent and Method for Potentiating the Effects of a Psychotropic Drug | 2019-01-10 |
20190008845 | PROGRAM RANDOMIZATION FOR CYBER-ATTACK RESILIENT CONTROL IN PROGRAMMABLE LOGIC CONTROLLERS | 2019-01-10 |
20190008846 | PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR | 2019-01-10 |
20190008847 | DOSAGE FORM OF VINCA ALKALOID DRUG | 2019-01-10 |
20190008848 | IDENTIFICATION OF ADDITIONAL ANTI-PERSISTER ACTIVITY AGAINST BORRELIA BURGDORFERI FROM AN FDA DRUG LIBRARY | 2019-01-10 |
20190008849 | ABUSE-PROOFED DOSAGE FORM | 2019-01-10 |
20190008850 | METHOD OF TREATING SCHIZOPHRENIA | 2019-01-10 |
20190008851 | Compositions And Kits Useful For Treatment Of Respiratory Illness | 2019-01-10 |
20190008852 | ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF | 2019-01-10 |
20190008853 | METHOD FOR TREATING A PROTOZOAL INFECTION | 2019-01-10 |
20190008854 | DRUG COMPRISING ARIPIPRAZOLE AND CILOSTAZOL | 2019-01-10 |
20190008855 | CANCER TREATMENT METHOD | 2019-01-10 |
20190008856 | INHIBITORS OF ATAXIA-TELANGIECTASIA MUTATED AND RAD3-RELATED PROTEIN KINASE (ATR) FOR USE IN METHODS OF TREATING CANCER | 2019-01-10 |
20190008857 | Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists | 2019-01-10 |
20190008858 | INHIBITORS OF HEPATITIS C VIRUS | 2019-01-10 |
20190008859 | Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor | 2019-01-10 |
20190008860 | AGENT FOR PREVENTING AND/OR TREATING ALZHEIMER'S DISEASE | 2019-01-10 |
20190008861 | METALLOENZYME INHIBITOR COMPOUNDS | 2019-01-10 |
20190008862 | PDE III INHIBITORS FOR TREATMENT OF ASYMPTOMATIC HEART FAILURE | 2019-01-10 |
20190008863 | PIMOBENDAN FOR THE REDUCTION OF HEART SIZE AND/OR THE DELAY OF ONSET OF CLINICAL SYMPTOMS IN PATIENTS WITH ASYMPTOMATIC HEART FAILURE DUE TO MITRAL VALVE DISEASE | 2019-01-10 |
20190008864 | PHARMACEUTICAL COMPOSITION CONTAINING GPR119 LIGAND AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | 2019-01-10 |
20190008865 | COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA | 2019-01-10 |
20190008866 | BROMODOMAIN INHIBITORS | 2019-01-10 |
20190008867 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS | 2019-01-10 |
20190008868 | FORMULATIONS, METHODS, KITS, AND DOSAGE FORMS FOR TREATING ATOPIC DERMATITIS AND FOR IMPROVED STABILITY OF AN ACTIVE PHARMACEUTICAL INGREDIENT | 2019-01-10 |
20190008869 | Therapeutic Combinations of an Antifolate and a BTK Inhibitor | 2019-01-10 |
20190008870 | COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER | 2019-01-10 |
20190008871 | STABLE CARFILZOMIB FORMULATIONS | 2019-01-10 |
20190008872 | METHOD OF TREATING REFRACTORY RHEUMATOID ARTHRITIS | 2019-01-10 |
20190008873 | NEUROACTIVE STEROID SOLUTIONS AND THEIR METHODS OF USE | 2019-01-10 |
20190008874 | Abiraterone Acetate Formulation and Methods of Use | 2019-01-10 |
20190008875 | STEROID ALKALOIDS AND COMPOSITIONS AND KITS THEREOF | 2019-01-10 |
20190008876 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND SUPPRESSING METASTASIS, CONTAINING SULFONAMIDE-BASED COMPOUND AS ACTIVE INGREDIENT | 2019-01-10 |
20190008877 | FORMULATION INCLUDING DOXYCYCLINE HYCLATE AND METHOD FOR ADMINISTERING THE SAME | 2019-01-10 |
20190008878 | COMPOSITIONS AND METHOD FOR REDUCING CARDIOTOXICITY | 2019-01-10 |
20190008879 | TREATMENT FOR CANCER BY A COMBINATION OF AN INOSITOL PHOSPHORIC DERIVATIVE AND MAGNESIUM CHLORIDE | 2019-01-10 |
20190008880 | Formulations and Dosage Forms of Oxidized Phospholipids | 2019-01-10 |
20190008881 | COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND OTHER DISORDERS | 2019-01-10 |
20190008882 | TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS | 2019-01-10 |
20190008883 | COMPOSITIONS COMPRISING NICOTINAMIDE RIBOSIDE AND A UROLITHIN | 2019-01-10 |
20190008884 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING AUTOPHAGY IN A SUBJECT IN NEED THEREOF | 2019-01-10 |
20190008885 | MIRNA BIOMARKERS FOR CARTILAGE DEGENERATION | 2019-01-10 |
20190008886 | a-SYNUCLEIN EXPRESSION INHIBITOR | 2019-01-10 |
20190008887 | MULTIMERIC MRNA | 2019-01-10 |
20190008888 | TLR INHIBITORY OLIGONUCLEOTIDES AND THEIR USE | 2019-01-10 |